SpringWorks Therapeutics Eulerpool Haberleri

SpringWorks Therapeutics Eulerpool News

SpringWorks Therapeutics Hisse Haberleri

SpringWorks Therapeutics, dünya çapında birçok gazeteci ve yatırımcı tarafından takip edilmektedir. En güncel SpringWorks Therapeutics haberlerini burada bir araya getiriyoruz.

• 5 Eylül ·

  Yahoo
  SpringWorks Therapeutics Inc (SWTX) CEO Saqib Islam Sells 49,000 Shares
• 4 Eylül ·

  TipRanks
  Springworks Therapeutics: Promising Outlook for Ogsiveo Drives Overweight Rating and Elevated Price Target
• 4 Eylül ·

  Thefly.com
  SpringWorks Therapeutics price target raised by $4 at JPMorgan, here's why
• 29 Ağustos ·

  SeekingAlpha
  Tracking Stanley Druckenmiller's Duquesne Family Office Portfolio - Q2 2024 Update
• 28 Ağustos ·

  Seeking Alpha
  FDA accepts SpringWorks' application for mirdametinib for NF1-PN
• 28 Ağustos ·

  Yahoo
  FDA Grants Priority Review to SpringWorks Therapeutics’ New Drug Application for Mirdametinib for the Treatment of Adults and Children with NF1-PN
• 28 Ağustos ·

  Seeking Alpha
  FDA accepts SpringWorks application for mirdametinib for NF1-PN
• 28 Ağustos ·

  TipRanks
  Buy Rating Affirmed for Springworks Therapeutics on Strong Outlook for Mirdametinib
• 28 Ağustos ·

  GlobeNewswire
  FDA Grants Priority Review to SpringWorks Therapeutics? New Drug Application for Mirdametinib for the Treatment of Adults and Children with NF1-PN
• 28 Ağustos ·

  Thefly.com
  SpringWorks Therapeutics: FDA grants priority review to NDA for mirdametinib